Asia Pacific Intranasal Drug And Vaccine Delivery Market Size & Outlook

The intranasal drug and vaccine delivery market in Asia Pacific is expected to reach a projected revenue of US$ 22,052.5 million by 2030. A compound annual growth rate of 7.1% is expected of Asia Pacific intranasal drug and vaccine delivery market from 2024 to 2030.
Revenue, 2023 (US$M)
$13,628.7
Forecast, 2030 (US$M)
$22,052.5
CAGR, 2024 - 2030
7.1%
Report Coverage
Asia Pacific

Asia Pacific intranasal drug and vaccine delivery market, 2018-2030 (US$M)

Asia

Related Markets

Asia Pacific intranasal drug and vaccine delivery market highlights

  • The Asia Pacific intranasal drug and vaccine delivery market generated a revenue of USD 13,628.7 million in 2023.
  • The market is expected to grow at a CAGR of 7.1% from 2024 to 2030.
  • In terms of segment, liquid delivery device was the largest revenue generating product in 2023.
  • Liquid Delivery Device is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, China is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 13,628.7 million
Market revenue in 2030USD 22,052.5 million
Growth rate7.1% (CAGR from 2023 to 2030)
Largest segmentLiquid delivery device
Fastest growing segmentLiquid Delivery Device
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPowder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler
Key market players worldwideGSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.6% of the global intranasal drug and vaccine delivery market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 22,052.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Intranasal Drug And Vaccine Delivery Market Companies

Name Profile # Employees HQ Website

Asia Pacific intranasal drug and vaccine delivery market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.


Liquid delivery device was the largest segment with a revenue share of 43.33% in 2023. Horizon Databook has segmented the Asia Pacific intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.


The intranasal drug and vaccine delivery market in Asia Pacific is anticipated to witness significant growth over the forecast period. Presence of developing countries such as China, India, and Japan is anticipated to boost market growth in Asia Pacific. These economies are now engaging in international trade through foreign direct investment.

In addition, rapidly growing medical tourism industry in these countries can also be attributed to the increase in the demand for various products used in intranasal drug and vaccine delivery in this region.

Reasons to subscribe to Asia Pacific intranasal drug and vaccine delivery market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific intranasal drug and vaccine delivery market databook

  • Our clientele includes a mix of intranasal drug and vaccine delivery market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific intranasal drug and vaccine delivery market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific intranasal drug and vaccine delivery market size, by country, 2018-2030 (US$M)

Asia Pacific Intranasal Drug And Vaccine Delivery Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific intranasal drug and vaccine delivery market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more